APA (7th ed.) Citation

García-Otín, A., Civeira, F., Aristegui, R., Díaz, C., Recalde, D., Sol, J. M., . . . Pocoví, M. (2002). Allelic polymorphism −491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment. European journal of clinical investigation, 32(6), 421-428. https://doi.org/10.1046/j.1365-2362.2002.00996.x

Chicago Style (17th ed.) Citation

García-Otín, A.-L, F. Civeira, R. Aristegui, C. Díaz, D. Recalde, J. M. Sol, X. Masramon, G. Hernández, and M. Pocoví. "Allelic Polymorphism −491A/T in Apo E Gene Modulates the Lipid-lowering Response in Combined Hyperlipidemia Treatment." European Journal of Clinical Investigation 32, no. 6 (2002): 421-428. https://doi.org/10.1046/j.1365-2362.2002.00996.x.

MLA (9th ed.) Citation

García-Otín, A.-L, et al. "Allelic Polymorphism −491A/T in Apo E Gene Modulates the Lipid-lowering Response in Combined Hyperlipidemia Treatment." European Journal of Clinical Investigation, vol. 32, no. 6, 2002, pp. 421-428, https://doi.org/10.1046/j.1365-2362.2002.00996.x.